Obesity and Fatty Liver Disease Are Increasing Globally
The prevalence of obesity and fatty liver disease is rising rapidly around the globe, largely due to the consumption of calorie-rich diets and a decline in physical activity. This growing trend poses significant health risks, including heart disease and other serious conditions.
Nitric oxide, a naturally occurring gas in the body, plays a crucial role in various biological functions. It interacts with proteins, influencing their activity. Maintaining an optimal level of nitric oxide is vital, as imbalances can lead to health issues.
Newly Discovered Enzyme Linked to Fat Production
Researchers at University Hospitals and Case Western Reserve University have identified a novel enzyme named SCoR2, which is essential for fat synthesis. This enzyme facilitates the removal of nitric oxide from proteins that control fat accumulation. By eliminating nitric oxide, the process of fat production is activated, highlighting the critical role of SCoR2.
Inhibition of SCoR2 Prevents Weight Gain in Animal Models
The research team explored the effects of inhibiting SCoR2 through both genetic techniques and a newly developed drug. In studies involving mice, blocking this enzyme not only halted weight gain but also shielded the liver from damage and decreased harmful cholesterol levels.
"Our innovative drug class not only prevents weight gain but also lowers cholesterol, offering a promising therapeutic option for obesity and cardiovascular health," stated Jonathan Stamler, MD, the study's lead author and a prominent figure at the Harrington Discovery Institute.
Nitric Oxide's Role in Fat and Cholesterol Regulation
According to Dr. Stamler, nitric oxide functions as a natural regulator of fat production across various tissues. In the liver, it inhibits the proteins responsible for fat and cholesterol synthesis, while in adipose tissue, it suppresses the genetic mechanisms that produce fat.
The research team is now preparing to advance their drug into clinical trials, anticipated to commence within the next 18 months.
"We are excited about the potential of this groundbreaking drug to prevent weight gain and improve cholesterol levels, with positive implications for liver health," Dr. Stamler added.
Support for Drug Development and Its Wider Implications
This promising drug is being developed with assistance from the Harrington Discovery Institute, dedicated to transforming scientific breakthroughs into viable treatments. Over its 13-year history, the institute has supported 227 medicines in development, launched 46 companies, and has 24 medicines currently undergoing clinical trials.